Egyptian Rheumatologist

Scope & Guideline

Empowering research, transforming care.

Introduction

Delve into the academic richness of Egyptian Rheumatologist with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1110-1164
PublisherELSEVIER
Support Open AccessYes
CountryEgypt
TypeJournal
Convergefrom 2011 to 2024
AbbreviationEGYPT RHEUMATOL / Egypt. Rheumatol.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The Egyptian Rheumatologist journal is dedicated to advancing knowledge in the field of rheumatology, focusing on the diagnosis, treatment, and management of various rheumatic diseases. The journal's scope encompasses a wide range of topics, emphasizing both clinical and translational research.
  1. Clinical Characteristics and Management of Rheumatic Diseases:
    The journal frequently publishes studies detailing the clinical features, management strategies, and outcomes of various rheumatic conditions, including systemic lupus erythematosus, rheumatoid arthritis, and spondyloarthritis.
  2. Biomarkers and Genetic Studies:
    Research on biomarkers, genetic variations, and their implications in rheumatic diseases is a core focus, with numerous papers exploring the role of interleukins and other molecular markers in disease activity and treatment response.
  3. Ultrasound and Imaging Techniques:
    The use of imaging modalities, particularly musculoskeletal ultrasound and MRI, is a significant area of interest, contributing to the understanding of disease activity, diagnosis, and treatment evaluation in rheumatology.
  4. Comorbidities and Extra-Articular Manifestations:
    The journal addresses the impact of comorbid conditions and extra-articular manifestations of rheumatic diseases, emphasizing the holistic management of patients.
  5. Patient Quality of Life and Psychosocial Aspects:
    There is a consistent focus on the quality of life, mental health issues, and psychosocial aspects related to rheumatic diseases, highlighting the importance of comprehensive care.
The Egyptian Rheumatologist has demonstrated a dynamic evolution in its research themes, particularly in recent years. Several emerging trends reflect the current priorities and innovations in the field of rheumatology.
  1. Role of Genetics and Molecular Biology:
    There is a growing trend towards exploring the genetic and molecular underpinnings of rheumatic diseases, with an emphasis on identifying genetic polymorphisms and their associations with disease susceptibility and treatment outcomes.
  2. Integrated Care Models:
    Emerging studies are focusing on integrated care models that address the multifaceted aspects of rheumatic diseases, including physical, psychological, and social dimensions of patient care.
  3. Impact of COVID-19 on Rheumatic Patients:
    The pandemic has prompted an increase in research examining the effects of COVID-19 on patients with rheumatic diseases, including the implications of vaccination and infection outcomes.
  4. Use of Advanced Imaging Techniques:
    The application of advanced imaging techniques, particularly ultrasound and MRI, for better diagnosis and monitoring of disease activity is increasingly prevalent in recent publications.
  5. Psychosocial Factors and Quality of Life:
    There is an emerging focus on the psychosocial factors affecting patients with rheumatic diseases, emphasizing the need to address mental health and quality of life in treatment paradigms.

Declining or Waning

While the Egyptian Rheumatologist continues to explore a variety of significant themes, some areas of research have seen a notable decline in focus over recent years. These waning scopes may reflect shifts in research priorities or the maturation of existing knowledge.
  1. Traditional Pharmacological Treatments:
    There is a noticeable decline in studies focusing solely on traditional pharmacological treatments for rheumatic diseases, as the journal increasingly emphasizes personalized medicine and newer therapeutic approaches.
  2. Epidemiological Studies:
    Research centered on the epidemiology of rheumatic diseases appears to be less prominent, possibly due to a shift towards more mechanism-based and patient-centered studies.
  3. Basic Science Research:
    There seems to be a waning interest in basic science research without direct clinical implications, as the journal prioritizes translational studies that bridge laboratory findings with clinical applications.

Similar Journals

Arthritis & Rheumatology

Advancing Knowledge in Rheumatology and Immunology
Publisher: WILEYISSN: 2326-5191Frequency: 12 issues/year

Arthritis & Rheumatology is a leading journal dedicated to the advancement of knowledge in the fields of rheumatology, immunology, and allergy. Published by WILEY in the United Kingdom, this prestigious journal boasts an impressive impact factor and a prominent reputation, ranking in the Q1 category across multiple disciplines, including Immunology and Rheumatology. With its high ranking of 4th out of 73 in Rheumatology and notable standings in related fields, it serves as a crucial platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings. The journal embraces an Open Access model, enhancing the accessibility of vital research to a global audience and ensuring that knowledge dissemination is maximized. Since its inception in 2014, Arthritis & Rheumatology has been at the forefront of impactful research, fostering collaboration and innovation in tackling complex challenges within these medical disciplines. Researchers looking to explore the latest advancements and engage with cutting-edge studies in these fields will find this journal to be an essential resource.

Lupus Science & Medicine

Unlocking breakthroughs in lupus science and medicine.
Publisher: BMJ PUBLISHING GROUPISSN: 2053-8790Frequency: 1 issue/year

Lupus Science & Medicine is a leading open-access journal published by the BMJ Publishing Group, dedicated to advancing the understanding and treatment of lupus and related autoimmune diseases. Since its establishment in 2014, the journal has fostered an academic environment for researchers, healthcare professionals, and students, providing a platform for high-quality, evidence-based studies. With a notable impact in the fields of immunology and rheumatology, it currently holds a Q1 ranking in Rheumatology and Medicine (miscellaneous) and Q2 in Immunology, reflecting its significant contribution to these vital areas of medical research. The journal is indexed in Scopus, with a commendable rank in the 67th percentile for Rheumatology, making it a valuable resource for those seeking the latest insights into lupus management and treatment. The journal emphasizes the importance of open access, ensuring that research findings are widely available to enhance global knowledge and collaboration in the fight against lupus.

JOINT BONE SPINE

Empowering knowledge in bone and joint diseases.
Publisher: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIERISSN: 1297-319XFrequency: 6 issues/year

JOINT BONE SPINE is a premier peer-reviewed journal dedicated to advancing knowledge in the fields of rheumatology and orthopedics. Published by Elsevier France-Editions Scientifiques Medicales Elsevier, this esteemed journal has established itself as a key resource within the academic community, being categorized in the Q2 quartile of rheumatology journals for 2023. With an impressive impact as denoted by its Scopus rank of #26 out of 73, and a noteworthy 65th percentile, JOINT BONE SPINE serves as a vital platform for innovative research and clinical findings that address bone and joint diseases. The journal promotes open access, which enhances the dissemination of research findings, ensuring that practitioners, researchers, and students alike can easily access the latest developments and methodologies in the field. With a commitment to bridging scientific advances from 2000 to the present and beyond, JOINT BONE SPINE plays a critical role in shaping the future of musculoskeletal medicine and improving patient outcomes worldwide.

Pediatric Rheumatology

Advancing pediatric care through groundbreaking research.
Publisher: BMCISSN: Frequency: 1 issue/year

Pediatric Rheumatology is a leading peer-reviewed open access journal published by BMC, dedicated to disseminating high-quality research in the field of pediatric rheumatology. Since its inception in 2007, the journal has established itself as a vital resource for healthcare professionals, researchers, and students focused on pediatric immunology, rheumatology, and child health, maintaining an impressive Q1 ranking in Pediatrics and Q2 in Immunology and Allergy as well as Rheumatology for 2023. It is recognized for its impact on advancing knowledge and clinical practice, with significant contributions noted in various studies and case reports. With access options that embrace the ethos of open science, all articles published in Pediatric Rheumatology are freely available, promoting collaborative research and discussion among practitioners across the globe. The journal welcomes submissions that encapsulate innovative research, clinical trials, and reviews that address both current challenges and advancements within the pediatric rheumatology landscape.

LUPUS

Exploring the complexities of rheumatology and autoimmune disorders.
Publisher: SAGE PUBLICATIONS LTDISSN: 0961-2033Frequency: 14 issues/year

LUPUS is a premier peer-reviewed journal published by SAGE Publications Ltd, focusing on the field of rheumatology, with a specific emphasis on the complexities of lupus and related autoimmune disorders. Since its inception in 1991, the journal has consistently ranked in the Q2 category within the rheumatology field, currently positioned as #29 out of 73 in Scopus, reflecting its significant contributions to research and clinical practice. The journal aims to foster a deeper understanding of lupus through the publication of original research articles, reviews, and clinical studies, making it an essential resource for researchers, clinicians, and students dedicated to advancing knowledge in this vital area of medicine. With an impact factor that underscores its influence, LUPUS serves as a critical platform for sharing innovative findings and engaging discussions within the global scientific community. Although the journal follows a traditional access model, it is situated in the United Kingdom, at 1 Olivers Yard, 55 City Road, London EC1Y 1SP, England, and remains dedicated to supporting the continuous advancement of research in autoimmune diseases.

Rheumatology and Therapy

Unlocking the future of rheumatology and therapy.
Publisher: SPRINGERISSN: 2198-6576Frequency: 4 issues/year

Rheumatology and Therapy, published by Springer, stands as a prominent open-access journal within the fields of Immunology and Allergy and Rheumatology. Since its inception in 2014, the journal has made significant contributions to advancing the understanding, diagnosis, and treatment of rheumatic diseases, garnering a solid reputation with an impact factor that reflects its rigorous peer-review process and scholarly influence. Currently ranked in the Q2 quartile for both its categories according to 2023 metrics, it occupies a significant position among its peers, standing at Rank #21 out of 73 in Medicine Rheumatology and Rank #101 out of 233 for Medicine Immunology and Allergy. The journal's scope encompasses cutting-edge research, reviews, and clinical studies that aim to bridge the gap between laboratory findings and patient care, making it an invaluable resource for researchers, clinicians, and students alike. With its commitment to open access, Rheumatology and Therapy ensures that high-quality research is available to a global audience, fostering collaboration and innovation in rheumatology and immunology. To learn more, visit their official site and explore the wealth of knowledge available.

Reumatologia

Advancing knowledge in Rheumatology and Immunology.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 0034-6233Frequency: 6 issues/year

Reumatologia is a dedicated open-access journal published by TERMEDIA PUBLISHING HOUSE LTD that has been serving the global scientific community since 2005. The journal focuses on the fields of Rheumatology, Immunology, and Allergy, providing a rich platform for researchers and practitioners to share innovative findings, clinical insights, and methodologies. With its roots tracing back to the early 1960s and a steady convergence of quality content through 2024, Reumatologia has secured a place in the academic landscape, currently holding a Q4 rating in Immunology and a Q3 rating in both Immunology and Allergy and Rheumatology categories for 2023. While the journal ranks #42 out of 73 in the Medicine - Rheumatology category, its open-access model ensures that research is widely disseminated, enhancing visibility and accessibility to vital knowledge that shapes therapeutic practices. Located in Poznan, Poland, Reumatologia remains a pivotal source of credible research, fostering collaboration among academics, healthcare professionals, and students internationally.

Egyptian Journal of Pediatric Allergy and Immunology

Illuminating the path to improved outcomes in pediatric allergies.
Publisher: EGYPTIAN SOC PEDIATRIC ALLERGY & IMMUNOLOGYISSN: 1687-1642Frequency: 2 issues/year

Welcome to the Egyptian Journal of Pediatric Allergy and Immunology, a leading academic platform dedicated to the advancement of knowledge in the field of pediatric allergy and immunology. Published by the prestigious Egyptian Society of Pediatric Allergy & Immunology, this journal aims to address the pressing challenges and breakthroughs in the diagnosis, treatment, and management of allergic diseases in children. As a crucial resource for researchers, healthcare professionals, and students, it focuses on disseminating high-quality, peer-reviewed articles that contribute to the global understanding of allergic conditions and immunological responses in pediatric populations. Although the journal is currently not an Open Access publication, it provides a valuable gateway to research findings that can shape clinical practice and influence future investigations. With an emphasis on contributing to improved healthcare outcomes for children suffering from allergy and immunology disorders, the Egyptian Journal of Pediatric Allergy and Immunology stands out as an essential reference in the field.

CURRENT OPINION IN RHEUMATOLOGY

Delivering Critical Insights for Tomorrow's Treatments
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1040-8711Frequency: 6 issues/year

Current Opinion in Rheumatology, published by Lippincott Williams & Wilkins, stands as a vital resource in the field of rheumatology. Since its inception in 1989, this prestigious journal has been at the forefront of disseminating cutting-edge research, with a notable Q1 ranking in the 2023 Rheumatology category and an impressive Scopus rank of 7 out of 73, placing it in the 91st percentile. The journal's commitment to presenting insightful reviews and critical analyses of recent advancements and treatment strategies makes it an essential read for professionals, researchers, and students dedicated to the study of rheumatic diseases. Although not an open-access journal, Current Opinion in Rheumatology continues to foster an informed dialogue within the academic community through its high-impact content, ensuring that the latest developments and practices are accessible to those at the vanguard of rheumatology research.

Modern Rheumatology

Exploring Breakthroughs in Rheumatic Disease Research
Publisher: OXFORD UNIV PRESSISSN: 1439-7595Frequency: 6 issues/year

Modern Rheumatology is a premier journal dedicated to advancing the field of rheumatology through high-quality peer-reviewed research. Published by Oxford University Press, this journal reflects the latest developments in rheumatologic medicine, catering to researchers, clinicians, and students alike. With an H-Index highlighting its scholarly impact, Modern Rheumatology occupies a notable position, ranking Q2 in both the fields of Medicine and Rheumatology in 2023, and is listed among the top 25 journals in its category by Scopus. Spanning from the year 2000 to 2024, the journal features a diverse array of topics aimed at addressing current challenges and innovations in the field. Although it does not offer Open Access, it provides essential insights for professionals seeking to stay abreast of evolving treatment modalities and research breakthroughs. Located in the heart of the United Kingdom, Modern Rheumatology is a vital resource for anyone committed to enhancing the understanding and treatment of rheumatic diseases.